Management of High-Risk Infantile Hemangiomas: A Clinical Guideline

Once high-risk hemangiomas are identified, infants should receive propranolol therapy or, alternatively, surgery for severe complications to the airway or orbit.

Sponsoring Organization: American Academy of Pediatrics (AAP)

Background and Objective

Most infantile hemangiomas (IHs) are benign and transient, requiring only observation. However, some may be serious, due to size or location, possibly leading to residual scarring or even acute respiratory or hemorrhagic complications. A multidisciplinary subcommittee of the AAP has created a new practice guideline for management of high-risk IH based on recent studies.

Key Points

Growth of superficial IHs is most rapid between ages 1 and 3 months and typically concludes by age 5 months.
A “high-risk” IH that might require early treatment is one with potential for causing life-threatening complications (airway obstruction, bleeding, congestive heart failure, s…

Reviewing Author

F. Bruder Stapleton, MD

Disclosures

Consultant/Advisory BoardCareer Physician

Editorial BoardsUpToDate

Leadership Positions in Professional SocietiesAmerican Society of Pediatric Nephrology Foundation (Chair)